624 related articles for article (PubMed ID: 32334981)
1. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
2. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
Botto GL; Forleo GB; Capucci A; Solimene F; Vado A; Bertero G; Palmisano P; Pisanò E; Rapacciuolo A; Infusino T; Vicentini A; Viscusi M; Ferrari P; Talarico A; Russo G; Boriani G; Padeletti L; Lovecchio M; Valsecchi S; D'Onofrio A;
Europace; 2017 Nov; 19(11):1826-1832. PubMed ID: 28011803
[TBL] [Abstract][Full Text] [Related]
3. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
5. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
6. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
[TBL] [Abstract][Full Text] [Related]
7. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
8. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
9. [The subcutaneous implantable cardioverter-defibrillator in clinical practice].
Migliore F; Mattesi G; Zorzi A; Viani S; Bongiorni MG; Francia P; Curcio A; Diemberger I; Bertaglia E
G Ital Cardiol (Rome); 2019 Nov; 20(11):641-650. PubMed ID: 31697271
[TBL] [Abstract][Full Text] [Related]
10. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
Verma N; Rhyner J; Knight BP
Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
[TBL] [Abstract][Full Text] [Related]
11. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.
Migliore F; Mattesi G; De Franceschi P; Allocca G; Crosato M; Calzolari V; Fantinel M; Ortis B; Facchin D; Daleffe E; Fabris T; Marras E; De Lazzari M; Zanon F; Marcantoni L; Siciliano M; Corrado D; Iliceto S; Bertaglia E; Zecchin M
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):854-864. PubMed ID: 30827041
[TBL] [Abstract][Full Text] [Related]
12. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
Karnik AA; Helm RH; Monahan KM
J Cardiovasc Electrophysiol; 2019 Mar; 30(3):402-409. PubMed ID: 30576031
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
Souza FSO; Matos VS; Almeida MCV; Weiss SC; Rodrigues LHB; Lima PAG; Mattos DB
Braz J Cardiovasc Surg; 2017; 32(6):498-502. PubMed ID: 29267613
[TBL] [Abstract][Full Text] [Related]
15. End-of-life of implantable defibrillator: are we certain it should always be replaced?
Stazi F
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
[No Abstract] [Full Text] [Related]
16. Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.
Garcia R; Degand B; Fraty M; Le Marcis V; Bidegain N; Laude D; Tavernier M; Le Gal F; Hadjadj S; Saulnier PJ; Ragot S
Arch Cardiovasc Dis; 2019 Apr; 112(4):270-277. PubMed ID: 30670362
[TBL] [Abstract][Full Text] [Related]
17. The wearable cardioverter-defibrillator: current technology and evolving indications.
Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
[TBL] [Abstract][Full Text] [Related]
18. Impact of routine right parasternal electrocardiographic screening in assessing eligibility for subcutaneous implantable cardioverter-defibrillator.
Arias MA; Pachón M; Sánchez-Iglesias I; Loughlin G; Martín-Sierra C; Puchol A; Sabatel F; Rodríguez-Padial L
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):103-111. PubMed ID: 31724763
[TBL] [Abstract][Full Text] [Related]
19. The implantable cardioverter-defibrillator: An update.
Miller JD; Yousuf O; Berger RD
Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
